Regulatory Open Forum

 View Only
Expand all | Collapse all

EU MDR 2nd corrigendum

  • 1.  EU MDR 2nd corrigendum

    Posted 07-Feb-2020 11:15
    Hello experts, I have a 2nd corrigendum question.

    My understanding is that only class 1r, 1s, and 1m devices are extended to 2024.

    However, we have a supplier who is telling us that dental impression materials have also been extended, and that I should read the 2nd corrigendum to confirm this.

    I cannot find anywhere in the 2nd corrigendum where these particular materials are extended. My only thought is that they think these are upclassified perhaps due to nano particles and the upclassification means impression materials get to stay on the market as a class 1 device until 2024.

    This doesn't make sense to me.

    Anyone else have any insight or knowledge?

    Thanks so much!

    ------------------------------
    Corey Jaseph RAC
    Director of Regulatory Affairs
    South Jordan UT
    United States
    ------------------------------


  • 2.  RE: EU MDR 2nd corrigendum

    Posted 07-Feb-2020 12:02
    As currently worded, the 2nd Corrigendum [i.e., the aspect attending to Article 120(3)] is limited in scope to Directive 93/42/EEC-compliant class I devices (i.e., those for which a 93/42/EEC declaration of conformity was drawn up prior to 26 May 2020) which pursuant to Regulation 2017/745 are class I devices that are sterile, have a measuring function, or that are reusable surgical instruments.

    ------------------------------
    Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
    Principal Consultant
    ComplianceAcuity, Inc.
    Golden, CO
    United States
    www.complianceacuity.com
    © Copyright 2020 by ComplianceAcuity, Inc. All rights reserved.
    ------------------------------



  • 3.  RE: EU MDR 2nd corrigendum

    Posted 07-Feb-2020 17:17

    The consensus among the interpretations I've read, including the explanation published by MedTech Europe, seems to be that it applies to all Class I devices that were self-certified (and therefore have drawn up a DoC) prior to May 26 and that, except for the Corrigendum, would need a certificate issued by an MDR-designated notified body in order to stay on the market starting May 26. 

    This interpretation would include software devices that were Class I and are being upclassified under the MDR.  I believe the MedTech Europe guidance specifically mentioned dental impression materials.

    If you search the forum for "Corrigendum," you will find a number of opinions, some discussion of the language, and links to the Corrigendum and to the MedTech Europe analysis.



    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 4.  RE: EU MDR 2nd corrigendum

    Posted 08-Feb-2020 04:33
    Hi Corey,

    it is like you already indicated. The COR2 includes the extended transition for all class I products with a valid DoC under the MDD which now require the N.B. assessment.
    (see https://www.quadras.de/2019/12/18/second-vortigendum-mdr-ivdr-approved-by-eu-parliament/)

    But keep in mind any change Leads to a mandatory application of the MDR.

    Best regards

    ------------------------------
    Bodo Mestmacher
    Essen
    Germany
    ------------------------------



  • 5.  RE: EU MDR 2nd corrigendum

    Posted 09-Feb-2020 21:43
    What happens if they make a change?  If they didn't have an NB under the MDD, the NB they don't have can't rescind their certification.  How would anyone know?  The MDR certificate will be an original certificate, based on whatever design is submitted for review.

    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 6.  RE: EU MDR 2nd corrigendum

    Posted 10-Feb-2020 02:34
    In Case of a change it is the manufacturers' obligation to apply for the C.A.P. with a notified body. This is the same responsibility as to identify significant changes under an existing 510(k). Although there is no inspection / audit it is the manufacturer to comply with the rules....

    ------------------------------
    Bodo Mestmacher
    Essen
    Germany
    ------------------------------



  • 7.  RE: EU MDR 2nd corrigendum

    Posted 10-Feb-2020 02:58
    ​It basically starts with and depends on the truthfulness of the manufacturer to start a CE certification with a Notified Body when they want to market a significantly changed device on the market. As far as I know all class I devices are notified at the corresponding Competent Authorities (it is in the Netherlands). The CA have to oversee these manufacturers.
    But that's nothing new, It always starts with the manufacturer being aware of their obligations and fulfil the regulatory requirement.

    ------------------------------
    Peter Reijntjes
    Principal Consultant Regulatory & Quality Affairs
    Arnhem
    Netherlands
    ------------------------------



  • 8.  RE: EU MDR 2nd corrigendum

    Posted 10-Feb-2020 04:31
    Corey,

    Yes, it basically applies to anything getting "up-classed" was self-declared under the MDD, i.e. Class I Reusable Surgical Instruments, some software.  In your case, those dental impression materials now might be considered absorbed materials ​under Rule 21 (or some other Rule) though would need more specific information on the device.  There are no Class Is under Rule 21 so the product you are citing might be "up-classed" not having a current MDD CE Certificate.

    ------------------------------
    Richard Vincins RAC
    Vice President Global Regulatory Affairs
    ------------------------------



  • 9.  RE: EU MDR 2nd corrigendum

    Posted 10-Feb-2020 09:20
    Edited by Julie Omohundro 10-Feb-2020 10:42
    "...depends on the truthfulness of the manufacturer..."

    In biblical terms, I believe this is what is known as building your house upon the sand. It would also seem to negate a need for any regulations whatsoever, except as government-funded opportunities to create jobs and profits, and to inspire consumer confidence.  It certainly suggests a lack of lessons learned from PIP.

    Regardless, what I think you are saying is that previously they were supposed to notify the CA, instead of a notified body?  But under the MDR, they will have to notify their notified body.  However, since they are under Corrigendum 2 because they can't find a notified body, they can't apply for the C.A.P. with a notified body.  One possibility is that they could be "required" to notify the CA instead, but I'm not going to dig through to ttry to figure out if a provision for this can be found in the gray of a voided MDD and the MDR and Corrigendum 2.

    If they don't notify their CA, then I'm doubtful the CA has any way of knowing.  If they notify their CA...who knows what the CA will do, most likely send them a form letter...perhaps informing them that they cannot make this change until they have applied for the C.A.P with a notified body, or perhaps the same form letter they have been sending out for decades, that may just acknowledge receipt of the notification.  Either way, whenever they finally find an NB, it seems like it's a clean slate, and they just submit the changed design.

    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 10.  RE: EU MDR 2nd corrigendum

    Posted 10-Feb-2020 05:42
    Excellent point, Julie!

    ------------------------------
    Roger Gray
    VP Quality and Regulatory
    Donawa Lifescience Consulting
    Clinical Studies - Regulatory - Quality Systems
    Rome, Italy
    +39 06 578 2665
    rgray@donawa.com
    www.donawa.com
    ------------------------------



  • 11.  RE: EU MDR 2nd corrigendum

    Posted 10-Feb-2020 10:42
    When I click on the link, I get Page Not Found.

    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 12.  RE: EU MDR 2nd corrigendum

    Posted 10-Feb-2020 12:51
    Sorry the link that is posted has an additional ")" so please try with this link: https://www.quadras.de/2019/12/18/second-vortigendum-mdr-ivdr-approved-by-eu-parliament/

    ------------------------------
    Bodo Mestmacher
    Regulatory Affairs Expert
    QUADRAS
    Essen
    Germany
    ------------------------------